EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The use of isophane insulin for the control of diabetes mellitus in dogs






Acta Veterinaria Scandinavica 33(3): 219-227

The use of isophane insulin for the control of diabetes mellitus in dogs

For this study 54 dogs with diabetes mellitus verified by anamnesis, clinical examinations and laboratory analyses were selected in 13 Danish and Swedish small animal clinics. After instruction the owners gave isophane insulin ("Insulin Protaphan Human") injections to the dogs morning and evening followed by a commercial or homemade meal rich in fibers. The veterinarians examined the treated dogs 5 times or more in the 90-day treatment period, preferably in the morning before injection and meal. In all 54 dogs the clinical symptoms disappeared a few days after isophane insulin injections, and 54% of the dogs were clinically healthy within 8 days. Within a month 96% of the dogs were normalized after therapy. Simultaneously the blood glucose levels were normalized in 64% of the dogs within 14 days and further 21% within 30 days. The urine glucose levels were normalized in 64% of the dogs within 14 days and for further 19% within 30 days. At the end of the study 48 out of the 54 diabetic dogs were clinically healthy, alert and free from symptoms of diabetes. The average dose of isophane insulin was for greater dogs 0.44 units per kg bw twice a day, for small dogs 0.79. Six dogs had been destroyed in the trial period for various reasons. One owner had injection troubles. Another owner was hospitalized and had to get rid of the dog. One dog developed advanced breast cancer, 1 went fierce and 2 developed cataracts. Four dogs had by 1 or 2 occasions shown hypoglycemic symptoms, which quickly disappeared after appropriate adjustments of insulin dosing, feeding schedule and exercise program. It can be concluded that isophane insulin is a highly suitable insulin preparation for a 2 injection per day treatment of diabetic dogs.

(PDF 0-2 workdays service: $29.90)

Accession: 002530393

PMID: 1442369



Related references

Treatment of diabetes mellitus in dogs using isophane insulin penfills and the use of serum fructosamine assays to diagnose and monitor the disease. Acta Veterinaria Scandinavica 38(2): 137-146, 1997

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (): Cd005613-Cd005613, 2007

Morning versus bedtime isophane insulin in type 2 (non-insulin dependent) diabetes mellitus. Diabetic Medicine 9(9): 826-833, 1992

Human isophane or lente insulin? A double blind crossover trial in insulin dependent diabetes mellitus. Archives of Disease in Childhood 65(12): 1334-1337, 1990

Action profile of a semisynthetic human isophane zinc insulin compared with customary isophane insulin. Diabete & Metabolisme 18(6): 445-450, 1992

Evaluation of an insulin zinc suspension for control of naturally occurring diabetes mellitus in dogs. Australian Veterinary Journal 78(12): 831-834, 2001

Evaluation of an insulin zinc suspension for control of naturally occurring diabetes mellitus in dogs. Australian Veterinary Journal 78(12): 831-834, December, 2000

Changes in erythrocyte insulin receptors in normal dogs and Keeshond dogs with inheritable, early onset, insulin dependent diabetes mellitus. Dissertation Abstracts International, B 47(6): 2337, 1986

Comparison of cartridge insulin Penmix 50:50/Isophane with soluble/Isophane in type I diabetic adolescents using a multiple injection regimen. Diabetes Research 22(2): 59-65, 1993

Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: Influence of diabetes control and intraportal insulin infusion. Diabetes Research and Clinical Practice 25(1): 1-12, 1994